Promoter mutation of telomerase reverse transcriptase (TERTp) is another emerging molecular marker which can stratify lower-grade gliomas and glioblastomas into prognostic subgroups, particularly in combination with IDH1 mutation [19–24]. The gene discussed is IDH1; the disease is glioblastoma.